The role of the urethrogram during simulation for localized prostate cancer.

Urethrograms on 89 consecutive patients with localized prostate cancer were evaluated retrospectively, and the inferior border of the treatment field based on this study was compared with the inferior border that would have been defined by using the lower border of the ischial tuberosities. An analysis of the relationship between the margin used and the dose at the inferior border of the prostate supported our policy of requiring a 2 cm margin for optimal coverage of the prostate. Inclusion of at least 1 cm of proximal penile urethra was essential to ensure this 2 cm margin. Based on this assumption, twenty-five percent of patients would have had an inadequate margin if the lower border of the ischial tuberosities had been used instead of the urethrogram to define the inferior border of the treatment field. Assuming that a margin of more than 3 cm inferiorly is excessive, 11% of patients would have had excessive urethral irradiation if the bottom of the ischial tuberosities had been used to define the inferior border. Combining these two extremes, more than one in three patients would have had an inappropriate inferior margin if the bottom of the ischial tuberosities had been used to define the inferior border of the treatment field. There was no apparent increase in morbidity as a result of the urethrograms or an increase in treatment related toxicity in association with using the treatment fields defined by urethrography. Computed tomography was complimentary in defining the apex of the prostate. These data support the routine use of the urethrograms during simulation for localized prostate cancer. The use of the lower border of the ischial tuberosities to define the inferior border of the treatment field is associated with an unacceptable risk of either underdosing the apical portion of the prostate or overdosing the urethra.

[1]  Shopfner Ce The normal urethrogram. , 1968 .

[2]  J. Mcaninch,et al.  Latent residual tumor following external radiotherapy for prostate adenocarcinoma. , 1978, The Journal of urology.

[3]  W. Sause,et al.  Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06. , 1988, International journal of radiation oncology, biology, physics.

[4]  D. McGowan The value of extended field radiation therapy in carcinoma of the prostate. , 1981, International journal of radiation oncology, biology, physics.

[5]  P. Rubin,et al.  Correlation of radiotherapeutic parameters and treatment related morbidity--analysis of RTOG Study 77-06. , 1986, International journal of radiation oncology, biology, physics.

[6]  P. Lange,et al.  Prostate specific antigen and local recurrence after radical prostatectomy. , 1990, The Journal of urology.

[7]  T. Stamey,et al.  Positive surgical margins at radical prostatectomy: importance of the apical dissection. , 1990, The Journal of urology.

[8]  G. Murphy,et al.  Quality control of radiation therapy in multi-institutional randomized clinical trial for localized prostate cancer. , 1988, Urology.

[9]  A. V. von Eschenbach,et al.  Stage C adenocarcinoma of the prostate. An analysis of 551 patients treated with external beam radiation , 1987, Cancer.

[10]  G E Hanks,et al.  Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate. , 1985, International journal of radiation oncology, biology, physics.

[11]  W. Sause,et al.  Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate--analysis of RTOG study 75-06. , 1987, International journal of radiation oncology, biology, physics.

[12]  S L Schoeppel,et al.  Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. , 1991, International journal of radiation oncology, biology, physics.

[13]  H. Pollack Clinical urography : an atlas and textbook of urological imaging , 1990 .

[14]  S. C. Prasad,et al.  Computed tomography in definitive radiotherapy of prostatic carcinoma, part 2: definition of target volume. , 1980, International journal of radiation oncology, biology, physics.

[15]  S. Schild,et al.  Prostate cancer: retrograde urethrography to improve treatment planning for radiation therapy. , 1991, Radiology.

[16]  P. Schellhammer,et al.  Local failure after definitive therapy for prostatic cancer. , 1987, The Journal of urology.

[17]  D P Byar,et al.  Carcinoma of the prostate: Prognostic evaluation of certain pathologic features in 208 radical prostatectomies , 1972 .

[18]  M. Goitein,et al.  Accuracy of radiation field alignment in clinical practice. , 1985, International journal of radiation oncology, biology, physics.

[19]  R. Gittes Carcinoma of the prostate. , 1991, The New England journal of medicine.

[20]  A. Porter,et al.  Prostate localization for the treatment planning of prostate cancer: a comparison of two techniques. , 1988, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.